Not exact matches
FDA
APPROVES FIRST AI - POWERED RETINOPATHY APP: The US Food and
Drug Administration (FDA) greenlit the marketing of IDx - DR, the first medical device that uses artificial intelligence (AI) to detect diabetic retinopathy — a leading cause of blindness among people with
diabetes.
Intarcia has completed several late - stage clinical trials in which it uses the pump to deliver a glucose - controlling
drug continuously for months — an idea, that if successful (and
approved by the FDA) could significantly help patients with type 2
diabetes, fewer than half of whom maintain the recommended glycemic levels.
Yet, it would take nearly 40 years for the
drug to be
approved in the United States as a treatment for type 2
diabetes.
By targeting different hormones that help the body manage its own insulin levels — and by reducing side effects such as weight gain — three
drugs recently
approved by the FDA avoid most of the major problems associated with past
diabetes treatments.
Moreover, epalrestat, a
drug that inhibits AKR1B1 and is
approved in Japan to treat peripheral neuropathies associated with
diabetes, was similarly able to block the growth and metastasis of human basal - like breast cancer cells.
The most widely reported involved a study by Cleveland Clinic cardiologist Steven Nissen showing that the
diabetes drug Avandia, FDA -
approved in 1999, raised the risk of heart attack by 30 to 40 percent.
Drugs that stimulate glucagon - like peptide - 1 have been previously
approved for type 2
diabetes, and in December 2014 one of these, Saxenda, was also
approved for obesity treatment.
This issue hit the headlines two years ago, when the FDA suddenly restricted the use of Avandia, a
drug that had been
approved to treat
diabetes.
In these mouse tests, WWL113 — without any optimization for use as a
drug — performed about as well as the FDA -
approved diabetes treatment rosiglitazone (Avandia).
In 2011, a patient newly diagnosed with type II
diabetes will likely receive the same
drug, metformin, that was first
approved in 1957.
Among the newly funded investigations are: the development of animal models of diabetic eye disease to learn how fenofibrate, a
drug clinically -
approved to treat cholesterol, protects the eye from
diabetes - related damage; the development of a specialized camera to capture how the retina's rods and cones (responsible for turning light energy into shapes and colors) work in health and how they fail in retinal diseases; and the exploration of mechanisms by which intestinal tract bacteria impact the health of the eye.
The latest example of the flaws in the process for getting pharmaceutical
drugs approved by the FDA is the
diabetes drug diabetes drug Avandia.
Metformin Repurposed Anti-Cancer
Drug Metformin, FDA
approved in 1994, is known as «the Good Anti-Diabetic
Drug», taken by 150 million people worldwide for control of blood sugar in Type Two
Diabetes.
The U.S. Food and
Drug Administration today
approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec / insulin aspart injection) to improve blood sugar (glucose) control in adults with
diabetes mellitus.
, this
drug was
approved for the treatment of type 2
diabetes.
The first and only insulin
approved by the US Food and
Drug Administration for treating both canine and feline
diabetes mellitus.
FDA
approves first generic Actos to treat type 2
diabetes, US Food and
Drug Administration, August 17, 2012
More Blog Posts: Severe Skin Reactions Caused by Stevens - Johnson Syndrome are Linked to Different Prescription and OTC Medications,
Drug Injury Lawyers Blog, August 29, 2012 Despite Actos Lawsuits, FDA
Approves Type 2
Diabetes Drug's Generic Version,
Drug Injury Lawyers Blog, September 5, 2012 Boston Dangerous
Drug Lawsuits: YAZ, Ocella, and Yasmin Birth Control Pills Linked to Deep Vein Thrombosis, Pulmonary Embolism, Stroke, Heart Attack, and Myocardial Infarction Side Effects, Boston Injury Lawyers Blog, June 19, 2012 Continue reading
Our office has closely followed developments with the
diabetes medication Invokana since it was first
approved by the Food and
Drug Administration (FDA).
Posted in Alcohol Treatment Life Insurance, decline,
diabetes,
Drug Treatment Life Insurance, insurance, life insurance, prostate cancer Tagged alcohol abuse treatment, angioplasty, basal cell carcinoma syndrome, cardiac bypass surgery, complant treatment, Drug Treatment Life Insurance, easily approved, gastric bypass surgery, guaranteed issue life insurance, insurance, life insurance, life insurance agent, life insurance approval, life insurance decline, melanoma, moles with dysplastic nevi, prescription drug abuse treatment, prostate cancer watchful waiting, prudentt treeatment, Type 1 diabetes, Type 2 diabetes, underwriting guidelines, well controlled 3 Respo
Drug Treatment Life Insurance, insurance, life insurance, prostate cancer Tagged alcohol abuse treatment, angioplasty, basal cell carcinoma syndrome, cardiac bypass surgery, complant treatment,
Drug Treatment Life Insurance, easily approved, gastric bypass surgery, guaranteed issue life insurance, insurance, life insurance, life insurance agent, life insurance approval, life insurance decline, melanoma, moles with dysplastic nevi, prescription drug abuse treatment, prostate cancer watchful waiting, prudentt treeatment, Type 1 diabetes, Type 2 diabetes, underwriting guidelines, well controlled 3 Respo
Drug Treatment Life Insurance, easily
approved, gastric bypass surgery, guaranteed issue life insurance, insurance, life insurance, life insurance agent, life insurance approval, life insurance decline, melanoma, moles with dysplastic nevi, prescription
drug abuse treatment, prostate cancer watchful waiting, prudentt treeatment, Type 1 diabetes, Type 2 diabetes, underwriting guidelines, well controlled 3 Respo
drug abuse treatment, prostate cancer watchful waiting, prudentt treeatment, Type 1
diabetes, Type 2
diabetes, underwriting guidelines, well controlled 3 Responses